How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,469 results for

Postpartum Office Visit

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Effects of early, computerized brief interventions on risky alcohol use and risky cannabis use among young people Full Text available with Trip Pro

the intervention. Additionally, there is no evidence for adverse effects. This means that brief, computerized interventions could be feasible ways of dealing with risky alcohol use among young people. The evidence on cannabis consumption is scarcer, suggesting the need for more research. 1 Background 1.1 DESCRIPTION OF THE CONDITION Risky use of alcohol or recreational drugs among young people remains a prominent public health issue (UN, 2003; UNODC, 2010). The United Nations Office on Drugs and Crime (UNODC (...) . While marijuana refers to the cannabis leaves or other crude plant material, the term hashish describes the drug produced by drying the resin exuded by the marijuana plant ( ). Cannabis is commonly smoked, with or without being mixed with tobacco, but can also be consumed orally. The United Nations Office on Drugs and Crime (UNODC) has estimated that between 2.9 to 4.3 percent of the world population aged 15‐64 (between 129 and 191 million people) used cannabis at least once in 2008 (UN, 2010a

2017 Campbell Collaboration

183. Adult Type 1 diabetes mellitus

Adult Type 1 diabetes mellitus Adult type 1 diabetes mellitus National Clinical Guideline No. 17 National Patient Safety Office Oifig Náisiúnta um Shábháilteacht Othar June 2018This National Clinical Guideline for adults with type 1 diabetes has been developed by the Guideline Development Group, supported by the HSE National Clinical Programme for Diabetes. Part of the process of developing this guideline involved contextualising (for Ireland) the National Institute for Health and Care (...) No. 17). Available at: http://health.gov.ie/national-patient-safety-office/ncec . Users of NCEC National Clinical Guideline must ensure they have the current version (hardcopy or softcopy) by checking the relevant section in the National Patient Safety Office on the Department of Health website: http://health.gov.ie/national-patient-safety-office/Membership of the Guideline Development Group (GDG) The GDG was chaired by Dr Kevin Moore, Consultant Endocrinologist. This National Clinical Guideline

2018 National Clinical Guidelines (Ireland)

184. Emergency Medicine Early Warning System (EMEWS) In Pilot Sites

a named individual/s to coordinate local EMEWS implementation e.g. a clinical facilitator. Quality of evidence: Moderate Strength of recommendation: Conditional Responsible person/s for implementation: Chief Executive Officer (CEO)/General Manager (GM), Clinical Director (CD) and Director of Nursing (DoN) Recommendation 15a An appropriately experienced and trained nursing resource is required 24 hours a day for post-triage assessment as this is new work distinct from triage and other current emergency (...) NCEC NCGs: • No. 1 National Early Warning Score (NEWS) in non-pregnant admitted adult patients • No. 4 Irish Maternity Early Warning System (IMEWS) in women with a confirmed pregnancy and for up to 42 days post-natally • No. 5 Communication (Clinical Handover) in Maternity Services • No. 6 Sepsis Management • No. 11 Communication (Clinical Handover) in Acute and Children’s Services • No. 12 Paediatric Early Warning System (PEWS) in Paediatric in-patients. This guideline makes recommendations

2018 National Clinical Guidelines (Ireland)

185. Paediatric Urology

epididymitis in boys: evidence of a post-infectious etiology. J Urol, 2004. 171: 391. 151. Yerkes, E.B., et al. Management of perinatal torsion: today, tomorrow or never? J Urol, 2005. 174: 1579. 152. Boettcher, M., et al. Clinical and sonographic features predict testicular torsion in children: a prospective study. BJU Int, 2013. 112: 1201. 153. Nelson, C.P., et al. The cremasteric reflex: a useful but imperfect sign in testicular torsion. J Pediatr Surg, 2003. 38: 1248. 154. Mushtaq, I., et al

2018 European Association of Urology

186. Male Hypogonadism

Endocrinol (Oxf), 2016. 85: 189. 27. Latif, T., et al. Semen Quality as a Predictor of Subsequent Morbidity: A Danish Cohort Study of 4,712 Men With Long-Term Follow-up. Am J Epidemiol, 2017. 186: 910. 28. Bojesen, A., et al. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab, 2003. 88: 622. 29. Tuttelmann, F., et al. Novel genetic aspects of Klinefelter’s syndrome. Mol Hum Reprod, 2010. 16: 386. 30. Abouassaly, R., et al. Sequelae of treatment (...) in long-term survivors of testis cancer. Eur Urol, 2011. 60: 516. 31. Eberhard, J., et al. Risk factors for post-treatment hypogonadism in testicular cancer patients. Eur J Endocrinol, 2008. 158: 561. 32. Puhse, G., et al. Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment. Int J Androl, 2011. 34: e351. 33. Shimon I., et al. Male prolactinomas presenting with normal testosterone levels. Pituitary, 2014. 17: 246. 34. Behre, H., et al., Andrology

2018 European Association of Urology

187. BTS Guidelines for the outpatient management of pulmonary embolism

in terms of other healthcare utilisation (hospital readmissions, emergency depart- ment visits and OP visits to a doctor’s office within 90 days). The only difference between the groups was a higher number of home nursing visits for LMWH administration, as expected, ii6 Howard LSGE, et al. Thorax 2018;73:ii1–ii29. doi:10.1136/thoraxjnl-2018-211539 BTS guideline in those treated as OPs compared with the IP group (348 vs 105 visits). There are two other UK studies which have reported data on LOS. Davies (...) ) T Wilkinson (UK) B Mohkelesi (USA) P Wolters (USA) Statistical Editors A Douiri (UK) C Flach (UK) C Jackson (UK) S Stanojevic (USA) R Szczesniak (USA) B Wagner (USA) Y Wang (UK) Journal Club Editor P Murphy (UK) President, British Thoracic Society Professor M Woodhead Editorial Office Thorax, BMA House, Tavistock Square, London WC1H 9JR, UK T: +44 (0)20 7383 6373 E: thorax@bmj.com Twitter: @ThoraxBMJ ISSN: 0040-6376 (print) ISSN: 1468-3296 (online) Disclaimer: Thorax is owned and published

2018 British Thoracic Society

188. Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection (...) , arthralgias, headache, oral ulcers, leukopenia, thrombocytopenia, or transaminase elevation). Rapid screening during labor and delivery or during the immediate postpartum period using the opt-out approach should be done for women who were not tested earlier in pregnancy or whose HIV status is otherwise unknown. Results should be available 24 hours a day and within 1 hour. If a rapid HIV test result in labor is reactive, antiretroviral prophylaxis should be immediately initiated while waiting

2018 American College of Obstetricians and Gynecologists

189. Labor and Delivery Management of Women With Human Immunodeficiency Virus Infection

to this document can be found on or by calling the ACOG Resource Center. While ACOG makes every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect (...) at the initial prenatal visit, 2–4 weeks after initiating (or changing) cART drug regimens; monthly until RNA levels are undetectable; and then at least every 3 months during pregnancy. Pregnant women infected with HIV whose viral loads are more than 1,000 copies/mL at or near delivery, independent of antepartum antiretroviral therapy, or whose levels are unknown, should be counseled regarding the potential benefit of and offered scheduled prelabor cesarean delivery at 38 0/7 weeks of gestation to reduce

2018 American College of Obstetricians and Gynecologists

190. Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

for Clinical Practice Diagnosis If TS is highly suspected or has been confirmed prenatally, a fetal echocardiogram should be performed. If congenital heart disease is confirmed, then follow-up care by a pediatric cardiologist is recommended to provide counseling on the anatomy and physiology of the specific defect, recommended site and mode of delivery, and postnatal multidisciplinary management plan. Diagnosis of a BAV or a left-sided obstructive lesion, whether prenatally or postnatally, in a female (...) are significantly lower than z scores based on a non-TS reference population. Suggestions for Clinical Practice When an infant or child is diagnosed with TS, TTE should be performed at the time of the diagnosis, even if the fetal echocardiogram or postnatal cardiac examination was normal. When an infant or child is diagnosed with TS, CMR should be performed as soon as it is feasible without the need for general anesthesia. When an adult is diagnosed with TS, cardiovascular screening with TTE and CMR at the time

2018 American Heart Association

191. Treatment for Bipolar Disorder in Adults: A Systematic Review

plans, providers, purchasers, government programs, and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input. If you have comments on this systematic review, they may be sent by mail to the Task Order Officer named below at: Agency (...) , Thao V, Sunderlin B. Treatment for Bipolar Disorder in Adults: A Systematic Review. Comparative Effectiveness Review No. 208. (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-2012-00016-I.) AHRQ Publication No. 18-EHC012-EF. Rockville, MD: Agency for Healthcare Research and Quality; Au g u st 2018. Posted final reports are located on the Effective Health Care Program search page. DOI: https://doi.org/10.23970/AHRQEPCCER208. iv v Preface The Agency for Healthcare

2018 Effective Health Care Program (AHRQ)

192. Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries

the effectiveness of community, workplace, and health care system–based programs and policies aimed at supporting and promoting breastfeeding, and to determine the association between breastfeeding and maternal health Key Messages • Baby-Friendly Hospital Initiative (BFHI) is associated with improved rates of breastfeeding initiation and duration. • Health care staff education combined with postpartum home visits may be effective for increasing breastfeeding duration. • Health care staff education alone (...) in collaboration with partners from the Centers for Disease Control and Prevention (CDC) and National Institutes of Health Office of Women’s Health. The Evidence-based Practice Center further refined the KQs. We sought input from a Technical Expert Panel on the final research protocol, which was posted on the AHRQ Web site on March 20, 2017, at https://effectivehealthcare.ahrq.gov/topics/breastfeeding/research-protocol/; our PROSPERO registration number is CRD42017079125. Literature Search Strategy Search

2018 Effective Health Care Program (AHRQ)

193. Depression: Adult and Adolescent

are critical and contribute to the likelihood of good follow-through on treatment. Patient education should include: • The cause, symptoms and natural history of major depression • Shared decision making about treatment options • Information on what to expect during treatment • Follow-up (office visits, e-mail, and/or telephone) In addition to patient education, supportive care includes emotional support and guidance. Providers can engage in behavioral activation by encouraging patients to consider (...) tapering in two to three steps over a period of 2–3 months may reduce the risk of relapse and allows for improved awareness before any symptoms of relapse become severe. • For patients who have been on treatment for prolonged periods, have recurrent depression, or have a history of hospitalization or suicide attempts, consider tapering more slowly, over a period of 4–6 months. • Follow-up visits: Schedule at least one phone contact or office visit during tapering of medications, and another one 2–3

2017 Kaiser Permanente Clinical Guidelines

194. Public health guidance on antenatal screening for HIV, hepatitis B, syphilis and rubella susceptibility in the EU/EEA ? addressing the vulnerable populations

a pregnancy or in the post-partum period – if there is no documented evidence of the rubella status, in accordance with the national recommendations. The expert panel opined that all countries should consider having guidelines on the management of unknown rash illnesses in pregnancy. Several countries have addressed this issue in guidance documents for rubella susceptibility screening (the Czech Republic, Germany, Greece, Luxembourg and Malta) or in a separate guidance (Denmark, France, the Netherlands (...) the target levels of = 95% for antenatal testing coverage and antenatal care (defined as at least one visit) [16]. In the EU/EEA, the percentage of women tested at least once during pregnancy was estimated as 95% or higher in 12/18 countries for HIV and in 14/18 countries for syphilis [1]. While global efforts for the elimination of MTCT of hepatitis B and congenital rubella syndrome do not clearly specify targets for antenatal screening testing, data on testing coverage exist for a fraction of EU/EEA

2017 European Centre for Disease Prevention and Control - Public Health Guidance

195. Management of Pregnancy

Postpartum visit B. Actions at Every Visit At every visit, assess: • Blood pressure • Body mass index (BMI) • Weight gain • Medication reconciliation • Need for consultation with advanced prenatal care provider (e.g., obstetrician or maternal-fetal medicine) for women at high risk for preterm delivery ( ) Recommendation 18 Note: Please see the below sections and . Standard of Pregnancy Care Routine Pregnancy Care C. Interventions by Weeks Gestation Intervention ? Screen for intimate partner violence (...) these guidelines does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor. Version 3.0 – 2018VA/DoD Clinical Practice Guideline for the Management of Pregnancy March 2018 Page 2 of 147 Prepared by: The Management of Pregnancy Work Group With support from: The Office of Quality, Safety and Value, VA, Washington, DC & Office of Evidence Based Practice, U.S. Army

2018 VA/DoD Clinical Practice Guidelines

196. WHO recommendations on home-based records for maternal, newborn and child health

the contributors involved. We gratefully acknowledge the funding support received from Japan International Cooperation Agency (JICA). The views of the funding body did not influence the content of this guideline.vi WHO recommendations on home-based records for maternal, newborn and child health Acronyms and abbreviations ANC antenatal care ANC4 antenatal care (four visits) APGAR appearance, pulse, grimace, activity and respiration score ARI acute respiratory infection CASP Critical Appraisal Skills Programme (...) WHO Department of Immunization, Vaccines and Biologicals JICA Japan International Cooperation Agency MCA WHO Department of Maternal, Newborn, Child and Adolescent Health MCH maternal and child health MD mean difference M&E monitoring and evaluation MNCH maternal, newborn and child health NHD WHO Department of Nutrition for Health and Development OHCHR United Nations Office of the High Commissioner for Human Rights OR odds ratio PICO population (P), intervention (I), comparator (C), outcome (O) PND

2018 World Health Organisation Guidelines

197. Clearing the Smoke on Cannabis: Maternal Cannabis Use during Pregnancy ? An Update

aspects of people’s lives, including mental and physical health, cognitive functioning, ability to drive a motor vehicle, and pre- and post-natal development among children. In this report—one in a series reviewing the effects of cannabis use on various aspects of human functioning and development (see Beirness & Porath, 2017; McInnis & Plecas, 2016; Kalant & Porath, 2016; McInnis & Porath, 2016)— the effects of prenatal cannabis exposure on offspring, including the birth outcomes, neurocognitive (...) proposed changes to medical marijuana regulations. Retrieved from http://www.cfpc.ca/ uploadedFiles/Health_Policy/CFPC_Policy_Papers_ and_Endorsements/CFPC_Policy_Papers/Medical%20 Marijuana%20Position%20Statement%20CFPC.pdf Colorado Department of Public Health and Environment. (2017). Marijuana pregnancy and breastfeeding guidance for Colorado health care providers prenatal visits. Retrieved from https://www.colorado.gov/pacific/ sites/default/files/MJ_RMEP_Pregnancy-Breastfeeding- Clinical

2018 Canadian Centre on Substance Abuse

198. Chronic Pelvic Pain

, 2006. 10: 287. 19. Ayorinde, A.A., et al. Chronic pelvic pain in women of reproductive and post-reproductive age: a population-based study. Eur J Pain, 2017. 21: 445. 20. Choung, R.S., et al. Irritable bowel syndrome and chronic pelvic pain: a population-based study. J Clin Gastroenterol, 2010. 44: 696. 21. Fenton, B.W. Measuring quality of life in chronic pelvic pain syndrome. Exp Rev Obstet Gynecol, 2010. 5: 115. 22. Baranowski, A.P. Chronic pelvic pain. Best Pract Res Clin Gastroenterol, 2009 (...) of presenting symptoms over time. Neurourol Urodyn, 2018. 201. Vancaillie, T., et al. Pain after vaginal prolapse repair surgery with mesh is a post-surgical neuropathy which needs to be treated - and can possibly be prevented in some cases. Aust N Z J Obstet Gynaecol, 2018. 202. Mellano, E.M., et al. The Role of Chronic Mesh Infection in Delayed-Onset Vaginal Mesh Complications or Recurrent Urinary Tract Infections: Results From Explanted Mesh Cultures. Female Pelvic Med Reconstr Surg, 2016. 22: 166. 203

2018 European Association of Urology

199. Best Practices across the Continuum of Care for the Treatment of Opioid Use Disorder

and post-natal care. 87 First Nations ? Bup/nal should be the first line treatment. 87 ? Transition from methadone to bup/nal when clinically or geographically indicated. 87 Individuals living with chronic pain ? Non-narcotic treatment should be considered first. 7 Opioid therapy can be considered if the benefits of treatment outweigh the potential risks. Treatment should be structured with check points to validate progress, and agreed upon actions in the event of non-compliance should be endorsed (...) office or in a specialized opioid agonist treatment clinic. System planning is required to ensure that quality services are available and competent providers are engaged to meet the needs and intensity levels of those seeking help. While reviewing the findings, the reader should consider that the evidence base related to substance use treatment is an evolving area of inquiry. Many components of practice are guided by expert opinion and even best practices are established based on varying strengths

2018 Canadian Centre on Substance Abuse

200. BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP)

on the use of PrEP 20 4.1.3.4 Drug resistance In the iPrEx trial, FTC-related drug resistance developed in two participants who had unrecognised acute HIV infection at baseline [19]. These individuals had a negative antibody test before starting PrEP, but later tested positive. In the PROUD study, two of the three participants with a positive HIV test at enrolment or the 4-week visit had FTC-related drug resistance; no resistance was detected in participants who acquired HIV post-randomisation [2 (...) College London Dan Clutterbuck Consultant HIV and Sexual Health, NHS Lothian, Monica Desai Consultant Epidemiologist, Public Health England Nigel Field Senior Lecturer, Consultant Clinical Epidemiologist, University College London Justin Harbottle Programme Officer, Terrence Higgins Trust, London Zahra Jamal Policy and Research Officer, NAZ, London Sheena McCormack Professor of Clinical Epidemiology, MRC Clinical Trials Unit at University College London Adrian Palfreeman Consultant HIV and Sexual

2018 British Association for Sexual Health and HIV

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>